Literature DB >> 11242116

Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states.

P Schaner1, N Richards, A Wadhwa, I Aksentijevich, D Kastner, P Tucker, D Gumucio.   

Abstract

Familial Mediterranean fever (FMF; MIM 249100) is an autosomal recessive disease characterized by recurrent attacks of fever with synovial, pleural or peritoneal inflammation. The disease is caused by mutations in the gene encoding the pyrin protein. Human population studies have revealed extremely high allele frequencies for several different pyrin mutations, leading to the conclusion that the mutant alleles confer a selective advantage. Here we examine the ret finger protein (rfp) domain (which contains most of the disease-causing mutations) of pyrin during primate evolution. Amino acids that cause human disease are often present as wild type in other species. This is true at positions 653 (a novel mutation), 680, 681, 726, 744 and 761. For several of these human mutations, the mutant represents the reappearance of an ancestral amino acid state. Examination of lineage-specific dN/dS ratios revealed a pattern consistent with the signature of episodic positive selection. Our data, together with previous human population studies, indicate that selective pressures may have caused functional evolution of pyrin in humans and other primates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242116     DOI: 10.1038/85893

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  42 in total

1.  Homology modeling provides insights into the binding mode of the PAAD/DAPIN/pyrin domain, a fourth member of the CARD/DD/DED domain family.

Authors:  Tong Liu; Ana Rojas; Yuzhen Ye; Adam Godzik
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Evolution and comparative genomics of odorant- and pheromone-associated genes in rodents.

Authors:  Richard D Emes; Scott A Beatson; Chris P Ponting; Leo Goodstadt
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

3.  Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome.

Authors:  Jennifer F Hughes; John M Coffin
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

4.  Structural and functional insights into the B30.2/SPRY domain.

Authors:  Jae-Sung Woo; Joon-Hyuk Imm; Chang-Ki Min; Kyung-Jin Kim; Sun-Shin Cha; Byung-Ha Oh
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

5.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Authors:  Jae Jin Chae; Young-Hun Cho; Geun-Shik Lee; Jun Cheng; P Paul Liu; Lionel Feigenbaum; Stephen I Katz; Daniel L Kastner
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

6.  Dobzhansky-Muller incompatibilities in protein evolution.

Authors:  Alexey S Kondrashov; Shamil Sunyaev; Fyodor A Kondrashov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

7.  Reconstructing large regions of an ancestral mammalian genome in silico.

Authors:  Mathieu Blanchette; Eric D Green; Webb Miller; David Haussler
Journal:  Genome Res       Date:  2004-12       Impact factor: 9.043

8.  Comparative evolutionary genomics of androgen-binding protein genes.

Authors:  Richard D Emes; Matthew C Riley; Christina M Laukaitis; Leo Goodstadt; Robert C Karn; Chris P Ponting
Journal:  Genome Res       Date:  2004-07-15       Impact factor: 9.043

9.  Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein.

Authors:  J G Ryan; S L Masters; M G Booty; N Habal; J D Alexander; B K Barham; E F Remmers; K S Barron; D L Kastner; I Aksentijevich
Journal:  Ann Rheum Dis       Date:  2009-11-23       Impact factor: 19.103

10.  Developments in the scientific and clinical understanding of autoinflammatory disorders.

Authors:  Helen J Lachmann; Philip N Hawkins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.